Oxybutynin Chloride Tablet
Product Images NDC 52817-260
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 52817-260). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Trupharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1. Mean R-oxybutynin Plasma Concentrations Following Three Doses Of Oxybutynin Chloride 5 mg Administered Every 8 Hours For 1 Day In 23 Healthy Adult Volunteers (Oxybutynin Chloride Tablets 2)
Figure 2.mean Steady-state (±sd) R-oxybutynin Plasma Concentrations Following Administration Of Total Daily Oxybutynin Chloride Tablet Dose Of 7.5 mg To 15 mg (0.22 mg/kg To 0.53 mg/kg) In Children 5 (Oxybutynin Chloride Tablets 3)
Oxybutynin Chloride Tablets, Usp, 5 mg, 100 Count (Oxybutynin Chloride Tablets 4)
This is a medication with the generic name Oxybutynin Chloride. The medication comes in a package with 100 tablets. Each Oxybutynin Chloride tablet contains 5mg. It is intended for adults to take one tablet two to four times a day, and for pediatric patients, one tablet two to three times a day. The medication can be dispensed in a tightly sealed, light-resistant container as defined by the USPINF. The storage temperature of the medicine should be between 20 and 25 degrees Celsius (66 to 77 degrees Fahrenheit). It is manufactured by Tulex Pharmaceuticals Inc. and distributed by TruPharma LLC. There is a warning to keep it out of children's reach.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.